SPF级实验兔研究进展

doi:10.3969/j.issn.1674-5817.2014.03.017

摘要/Abstract

摘要： SPF级实验兔的研究始于1950年代末,至今已有50多年的发展历程。为更好了解国内外SPF级实验兔的发展状况,为今后的研究提供更丰富的资料,本文从SPF级实验兔的培育和饲养管理、生物学特性和应用研究三个方面进行阐述。

Abstract: The study of SPF rabbits has lasted more than 50 years from the late 1950s. In this paper, the breeding, biological characteristics, feeding and management, and applied research of SPF rabbits were made a detailed exposition to have a better understanding about the development status of SPF rabbits at home and abroad, and to provide more abundant information for future study.

Key words: SPF rabbits, Feeding and management, Biological characteristics, Application

中图分类号:

Q95-33

郭中坤, 王可洲, 吕素军. SPF级实验兔研究进展[J]. 实验动物与比较医学, 2014, 34(3): 249-254.

GUO Zhong-kun, WANG Ke-zhou, LV Su-jun. Advances in Research of SPF Rabbits[J]. Laboratory Animal and Comparative Medicine, 2014, 34(3): 249-254.

参考文献

[1] Wostmann BS, Pleasants JR.Rearing of germ-free rabbits[J]. Proceedings of the Animal Care Panel, 1959, (9):47-54.
[2] 王刚, 刘科, 赵伟健, 等. 我国SPF新西兰兔培育和生物学特性研究方面的进展[J]. 实验动物与比较医学, 2010, 30(3):229-232.
[3] Scher S, Collins GR, Weisbroth SH.The establishment of a specific-pathogen-free rabbit breeding colony.Ⅰ.Procedures for establishment and maintenance[J]. Laboratory Animal Care, 1969, 19(6):610-616.
[4] Syukuda Y.Rearing of germfree rabbits and establishment of an SPF rabbit colony[J]. Jikken Dobutsu, 1979, 28(1):39-48.
[5] Baba E, Kusanagi M, Fukata T, et al.Establishment of specific pathogen-free rabbits by inoculation of hysterectomy-derived rabbits with fecal suspension and anaerobic bacteria[J]. Lab Anim Sci, 1987, 37(6):765-768.
[6] Watanabe N, Nakagawa H, Kitajima S, et al.Establishment of a SPF colony of human apo(a) transgenic rabbits by frozen-thawed embryo transfer[J]. Exp Anim, 2005, 54(4):353-357.
[7] 秦川. 医学实验动物学[M]. 北京: 人民卫生出版社, 2008:105-107.
[8] 涂新明, 寿克让. SPF及清洁级种兔的培育[J]. 中国实验动物学杂志, 2001, 11(4):37-40.
[9] 张业彬, 王荫槐, 陈昱凯, 等. SPF家兔种群的建立[J]. 中国比较医学杂志, 2004, 14(1):34-36.
[10] Trávnícek J, Mandel L.Gnotobiotic techniques. Folia Microbiol (Praha), 1979, 24(1):6-10.
[11] Trexler PC, Reynolds LI.Flexible Film Apparatus for the Rearing and Use of Germfree Animals[J]. Appl Microbiol, 1957, 5(6):406-412.
[12] 李增强,孙淑华,孟金萍,等. 无菌兔、SPF兔和普通兔脏器系数的比较[J]. 中国比较医学杂志, 2009, 19(1):37-40.
[13] 王刚, 张富发, 刘科, 等. 离乳1周SPF级与普通级新西兰兔血液学参数比较[J]. 实验动物科学, 2010, 27(2):26-29.
[14] 徐平, 唐浩泉, 顾志明. 兔隔离器(SPF兔)[P]. 江苏: CN3527366, 2006-05-10.
[15] 李明勇, 李即良, 尤启龙, 等. 三通道卫生高效生产型SPF级别实验兔屏障环境兔舍[P]. 山东: CN201894105U, 2011-07-13.
[16] Ley FJ, Bleby J, Coates ME, Paterson JS.Sterilization of laboratory animal diets using gamma radiation[J]. Laboratory Animals, 1969, 3:221-254.
[17] Chen QL, Ha YM, Chen ZJ.A study on radiation sterilization of SPF animal feed[J]. Radiation Physics and Chemistry, 2005, 7:329-330.
[18] 朱佳廷,夏文幼,汪兴海,等. SPF试验动物饲料的辐照灭菌[J]. 核农学通报, 1995, 16(3):171-175.
[19] 朱佳廷, 夏文幼, 谢宗传, 等. 辐照灭菌饲料对SPF试验动物(兔)生长发育的影响[J]. 核农学通报, 1996, 17(2):77-79.
[20] Gotoh H, Tonooka M, Nakayama S, et al.Effect of trapidil on experimental hyperlipemia and atherosclerosis induced by cholesterol diet in SPF Japanese white rabbits[J]. Nihon Yakurigaku Zasshi, 1983, 82(5):303-319.
[21] Sebesteny A, Sheraidah GA, Trevan DJ, et al.Lipid keratopathy and atheromatosis in an SPF laboratory rabbit colony attributable to diet[J]. Lab Anim, 1985, 19(3):180-188.
[22] 黎雄才, 赵伟健, 张富发, 等. 铬对SPF级新西兰兔繁殖性能的影响[J]. 实验动物科学, 2012, 29(2):26-28.
[23] 袁进, 顾为望, 徐名衬. 屏障系统内SPF兔与普通级兔生长发育和繁殖性能的比较观察[J]. 中国养兔, 2003, (6):33-35.
[24] 马丽颖, 刘双环, 王洪, 等. SPF级和普通级新西兰家兔遗传背景差异的探讨[J]. 中国比较医学杂志, 2006, 16(10):591-594.
[25] 袁进, 顾为望, 张嘉宁, 等. SPF级和普通级新西兰兔主要脏器系数的比较[J]. 中国比较医学杂志, 2006, 16(12):749-751.
[26] 张嘉宁, 顾为望, 吴清洪, 等. SPF新西兰兔心电图测定[J]. 动物医学进展, 2005, 26(9):116-117.
[27] 徐文瑜, 杜颖, 任珺, 等. 普通级与SPF级家兔体温变化的比较[J]. 实验动物科学, 2007, 24(5):19-23.
[28] 温靖, 顾为望, 杨海英. SPF级新西兰兔血液生理生化指标的测定[J]. 动物医学进展, 2005, 26(1):81-83.
[29] 刘科, 王刚, 赵伟健, 等. 不同性别、年龄SPF级新西兰免血液生理生化参数比较[J]. 实验动物与比较医学, 2009, 29(1):40-43.
[30] Fong IW, Chiu B, Viira E, et al.Rabbit model for Chlamydia pneumoniae infection[J]. J Clin Microbiol, 1997, 35(1):48-52.
[31] Kreuter KA, El-Abbadi N, Shbeeb A, et al.Development of a Rabbit Pleural Cancer Model by Using VX2 Tumors[J]. Comp Med, 2008, 58(3):287-293.
[32] Altmann S, Emanuel A, Toomey M, et al.A Quantitative Rabbit Model of Vaccinia Keratitis[J]. Invest Ophthalmol Vis Sci, 2010, 51(9):4531-4540.
[33] Zhang G, Zhu B, Shi W, et al.Evaluation of mycobacterial virulence using rabbit skin liquefaction model[J]. Virulence, 2010, 1(3):156-163.
[34] Ma H, Zheng L, Liu Y, et al.Experimental infection of rabbits with rabbit and genotypes 1 and 4 hepatitis E viruses[J]. PLoS One, 2010, 5(2):e9160.
[35] Cheng X, Wang S, Dai X, et al.Rabbit as a Novel Animal Model for Hepatitis E Virus Infection and Vaccine Evaluation[J]. PLoS One, 2012, 7(12):e51616.
[36] Shi T, Bao G, Fu Y, et al.A low-virulence Eimeria intestinalis isolate from rabbit (Oryctolagus cuniculus) in China: molecular identification, pathogenicity, and immunogenicity[J]. Parasitol Res, 2014, 113(3):1085-1090.
[37] 谭德讲, 杜颖, 张潇, 等. 美国、欧洲、日本和中国药典中家兔热原检测法的主要差异及分析[J]. 药物分析杂志, 2008, 28(12):2149-2155.
[38] 吴清洪, 陈丽, 那顺巴亚尔, 等. SPF级新西兰兔用于热原检查的试验探讨[J]. 实验动物与比较医学, 2008, 28(3):174-176.
[39] 王金恒, 杜颖, 蔡彤, 等. SPF家兔和普通家兔在热原实验中的比较研究[J]. 药物分析杂志, 2011, 31(9):1764-1769.
[40] Gilman AP, Villeneuve DC, Secours VE, et al.Uranyl nitrate:91-day toxicity studies in the New Zealand white rabbit[J]. Toxicol Sci, 1998, 41(1):129-137.
[41] York RG, Brown WR, Girard MF, et al.Oral (drinking water) developmental toxicity study of ammonium perchlorate in New Zealand White rabbits[J]. Int J Toxicol, 2001, 20(4):199-205.
[42] Jean SM, Sharma P, Taylor D, et al.Cyclosporine-Induced Gingival Overgrowth in New Zealand White Rabbits (Oryctolagus cuniculus)[J]. Comp Med, 2009, 59(4):357-362.
[43] Yee SB, Dyer DN, Twenhafel NA, et al.Transient lipopolysaccharide-induced resistance to aerosolized Bacillus anthracis in New Zealand white rabbits[J]. Comp Med, 2013, 63(3):252-261.
[44] Liu P, Du RJ, Wang L, et al.Management of Hepatitis E Virus (HEV) Zoonotic Transmission: Protection of Rabbits against HEV Challenge following Immunization with HEV 239 Vaccine[J]. PLoS One, 2014, 9(1):e87600.